Hosted on MSN
Quest launches flow cytometry MRD test for myeloma
Quest Diagnostics has introduced a new flow cytometry measurable residual disease (MRD) blood test for myeloma, a cancer arising from abnormal plasma cells. The test aims to enhance ultra-sensitive ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
EmeritusDX, a CAP-accredited and CLIA-certified diagnostic laboratory, today announced the availability of advanced ...
While thrombocytopenia and bleeding are events that often occur together in neonates, this may not signify cause and effect. In fact, one study reported that 91% of neonates with low platelet counts ...
Multiparametric flow cytometry—a test that is widely accessible, cost-effective and timely—can find one cancerous cell hidden among thousands of healthy cells following treatment for acute myeloid ...
Sysmex America, Inc., a leading diagnostic solutions company offering hematology, urinalysis, information systems and flow cytometry testing technology for optimal clinical laboratory performance, ...
SAN ANTONIO--(BUSINESS WIRE)-- bioAffinity Technologies’ (Nasdaq: BIAF; BIAFW) Vice President of Diagnostics, Jennifer Rebeles, Ph.D., was part of a panel of worldwide experts that published the ...
CellCarta Establishes Strategic Partnership with Waters to Advance Companion Diagnostics Development
CellCarta, a leading global CRO laboratory to the biopharmaceutical industry, today announced a strategic partnership with Waters Corporation, a global leader in life sciences and diagnostics, ...
Back in December 2019, a cluster of patients in Wuhan, China, developed pneumonia of an unknown etiology. Since then, the full genome of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results